Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Galectin Therapeutics Inc (NASDAQ:GALT)

3.27
Delayed Data
As of 3:59pm ET
 +0.07 / +2.19%
Today’s Change
0.49
Today|||52-Week Range
3.68
+233.74%
Year-to-Date
Can Myriad Genetics (MYGN) Spring a Surprise in Q3 Earnings?
Apr 24 / Zacks.com - Paid Partner Content
IDEXX Laboratories (IDXX) Q1 Earnings: Surprise in Store?
Apr 18 / Zacks.com - Paid Partner Content
Will Henry Schein (HSIC) Deliver a Surprise in Q1 Earnings?
Apr 24 / Zacks.com - Paid Partner Content
Can Illumina (ILMN) Spring a Surprise this Earnings Season?
Apr 17 / Zacks.com - Paid Partner Content
Edward Lifesciences (EW) Q1 Earnings: A Surprise in Store?
Apr 20 / Zacks.com - Paid Partner Content
5 Drug Stocks That Could Be Big Winners this Earnings Season
Apr 17 / Zacks.com - Paid Partner Content
Can Mead Johnson (MJN) Spring a Surprise in Q1 Earnings?
Apr 20 / Zacks.com - Paid Partner Content
Integra LifeSciences (IART) Q1 Earnings: A Beat in Store?
Apr 13 / Zacks.com - Paid Partner Content
ResMed (RMD) Q3 Earnings: Disappointment in the Cards?
Apr 18 / Zacks.com - Paid Partner Content
GNC Holdings (GNC) Q1 Earnings: Disappointment in Store?
Apr 12 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close3.20
Today’s open3.21
Day’s range3.19 - 3.37
Volume542,891
Average volume (3 months)614,570
Market cap$109.0M
Dividend yield--
Data as of 3:59pm ET, 04/25/2017

Growth & Valuation

Earnings growth (last year)+13.64%
Earnings growth (this year)+24.34%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book34.50

Competitors

 Today’s
change
Today’s
% change
VRMLVermillion Inc+0.05+2.73%
TRIBTrinity Biotech PLC+0.39+7.12%
CGIXCancer Genetics Inc-0.05-1.19%
APHBAmpliPhi Biosciences...-0.29-8.19%
Data as of 4:01pm ET, 04/25/2017

Financials

Next reporting dateMay 12, 2017
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$0.00
Annual profit (last year)-$21.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Chief Medical Officer &
Director
Peter G. Traber
Chief Operating Officer &
Secretary
Harold H. Shlevin
Corporate headquarters
Norcross, Georgia

Forecasts


Search for Jobs